Ropes & Gray Advises Signant Health, Genstar Capital Portfolio Company, in its Acquisition of VirTrial

In The News
December 15, 2020

Ropes & Gray advised Signant Health, a portfolio company of Genstar Capital, in its acquisition of VirTrial, a leading provider of software solutions for remote site startup and decentralized clinical trial conduct. The transaction was announced on Nov. 30. The press release is here. 

Signant Health is the leading enabler of evidence generation for modern clinical trials. By adding the capabilities of VirTrial, Signant Health now expands its software stack to further digitally enhance trial sites and offer sponsors superior evidence generation across traditional, decentralized, and hybrid trial models. Genstar Capital is a leading private equity firm focused on investments in targeted segments of the financial services, healthcare, industrial, and software industries. 

The Ropes & Gray team that represented Signant Health was led by private equity partner Howard Glazer, and included private equity partner Minh-Chau Le (both of San Francisco), tax partner Leo Arnaboldi III (New York), IP transactions Megan Baca (Silicon Valley), employment, executive compensation and benefits counsel Ellen Sueda (San Francisco), and health care partner Eve Brunts (Boston).